Promising Results in Immunity Pharma’s Interim Phase 1/2a IPL344 in ALS Study
The new treatment being developed by Immunity Pharma may give ALS (Lou Gehrig’s Disease) patients hope. ALS is an “orphan
Read moreThe new treatment being developed by Immunity Pharma may give ALS (Lou Gehrig’s Disease) patients hope. ALS is an “orphan
Read more